Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

$6.3 billion and $6.5 billion.
  • Total Actavis Specialty Brands segment revenue of between $550 million and $600 million.
  • Total Anda Distribution segment revenue of between $1.0 billion and $1.2 billion.
  • Adjusted non-GAAP earnings for 2013 is expected to be between $7.70 and $8.10 per diluted share.*
  • Adjusted EBITDA for 2013 is expected to be between $1.87 billion and $1.94 billion.*
  • *See Tables 6 and 7 and accompanying notes. 

    Webcast and Conference Call DetailsActavis will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter and full year 2012 results, the outlook for 2013 and recent corporate developments.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573.  The Conference ID is 94810189.

    A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

    About Actavis, Inc.
    Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

    Actavis is the world's third-largest generics prescription drug manufacturer.&
    '/>"/>

    SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, ... Roger Crystal , MD as Vice President of ... Global Business Development Product Acquisition & Licensing team at ... developing business strategy and partnerships in the precision medicine ... partner with biotechnology and pharmaceutical companies across the spectrum ...
    (Date:7/28/2014)... July 28, 2014   Cardioxyl Pharmaceuticals, Inc. ... demonstrating that CXL-1427, a novel potential treatment for acute ... volunteers. The company has now initiated dosing of hospitalized ... clinical trial designed to further evaluate the drug,s safety ... The Phase I clinical trial evaluated the safety ...
    (Date:7/28/2014)... and NEW PROVIDENCE, N.J. , July ... are invited to meet with Linde,s Healthcare division ... to be held at McCormick Place in ... "Hospitals demand nothing less than complete confidence in ... , Linde,s Healthcare Segment manager. "Linde understands the importance ...
    Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
    ... Sept. 1 /PRNewswire-Asia-FirstCall/ -- ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
    ... Insert From Carl Zeiss Meditec -- CLERMONT-FERRAND, France, September 1, 2010 ... ... lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
    Cached Medicine Technology:Yongye International Announces RMB 400 Million Revolving Credit Facilities 2Yongye International Announces RMB 400 Million Revolving Credit Facilities 3Yongye International Announces RMB 400 Million Revolving Credit Facilities 4Yongye International Announces RMB 400 Million Revolving Credit Facilities 5Yongye International Announces RMB 400 Million Revolving Credit Facilities 6Yongye International Announces RMB 400 Million Revolving Credit Facilities 7Yongye International Announces RMB 400 Million Revolving Credit Facilities 8French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 2French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 3French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 4French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 5French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 6French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 7
    (Date:7/28/2014)... published in the July, 2014, issue of the ... by Northwestern Medicine researchers, sheds new light on ... endoscopic resection in the treatment of localized, early-stage ... surgical resection, while more invasive, provided significantly better ... for patients than endoscopic resection, which had a ...
    (Date:7/28/2014)... 2014 Mediaplanet announced distribution ... March 12th, a campaign that aims to raise awareness ... with industry leader TEALUX , a premium loose ... the campaign provides readers with educational insight about the ... propel the industry forward and make conscious organic choices ...
    (Date:7/28/2014)... July 28, 2014 The Healthcare ... graduates of its Advanced Training Program in Healthcare ... roles in their health care organization ranging from ... methodology of continuous quality improvement in the health ... Dr. Brent James’ internationally recognized Advanced Training Program ...
    (Date:7/28/2014)... have been forced to accept the diagnosis "growing pains" ... new PhD study involving 3,000 adolescents has now shown ... can see from the study that one in three ... experience problems with pain in their knees. Seven percent ... front of the knee," says physiotherapist and PhD Michael ...
    (Date:7/28/2014)... Brea, CA (PRWEB) July 28, 2014 ... management business process outsourcing (BPO) for Fortune 500 brands, ... 2,500 jobs across its locations in Wisconsin, California, Florida ... will be based at its Brea campus. , A ... clients, which have seasonal ramp-ups that require additional staffing ...
    Breaking Medicine News(10 mins):Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Many people never grow out of their growing pains 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 2Health News:Alta Resources to Fill Approximately 700 Positions in Brea 3
    ... , ... the North Shore. , ... MA (Vocus) May 25, 2010 -- Blue Cross Blue Shield of Massachusetts, Inc. ... a five-year Alternative Quality Contract (AQC). The agreement marks the first North Shore ...
    ... Massachusetts Medical School report in the journal Nature Medicine ... malignant glioma, a pathway essential to the cancer,s ability ... that would stop the cancer,s ability to thrive. ... RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway ...
    ... But bad news is the prevalence of hypertension in U.S. ... While the number of Americans with high blood pressure has ... news is that more people with the condition have it ... is a major risk factor for heart attack, stroke and ...
    ... the the human intestinal tract may be associated with ... the University of Florida present their research today at ... Microbiology in San Diego, CA. "Our findings suggest ... subjects with polyps, early lesions that can develop into ...
    ... By layering dB-Bloc ... noise bleeding through a common surface. For new build or existing finished walls, discover ... ... noise from the next through a common wall or ceiling assembly is no longer an impossible ...
    ... as fast, researchers report , TUESDAY, May 25 (HealthDay News) ... research suggests bacteria could indeed, at least if you spend ... looked at mycobacterium vaccae , a kind of natural ... the germ when they spend time in nature, researcher Dorothy ...
    Cached Medicine News:Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 2Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 3Health News:Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract 4Health News:Novel RNA interference screening technique identifies possible path for malignant glioma treatment 2Health News:Report Finds Control of High Blood Pressure Improving 2Health News:Report Finds Control of High Blood Pressure Improving 3Health News:Share Your Walls, Not the Noise. Introducing dB-Bloc for Common Wall Sound Bleed 2Health News:Germs in Soil Might Give Learning a Boost 2
    ... Anion traces: chloride (Cl) ≤ 500 mg/kg sulfate (SO ... 500 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 5 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
    Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
    Inquire...
    Inquire...
    Medicine Products: